News and Updates for Healthcare Professionals

AHRQ request information on best care for persons with multiple chronic conditions

On September 16th, the Agency for Healthcare Research and Quality (AHRQ) published a Request for Information (RFI) in the Federal Register seeking public comment about comprehensive, longitudinal, person-centered care planning for people at risk for or living with Multiple Chronic Conditions (MCC). We encourage you or others in your organization to review the RFI and submit comments. We also encourage you to share this information with others in your network. Comments can be submitted until November 15, 2022.

Specifically, the RFI seeks comment on the current state of comprehensive, longitudinal, person-centered care planning for people at risk for or living with MCC across settings of care (e.g., health systems, primary care, home, and other ambulatory practices), including:

  • Existing models of person-centered care planning, their current scale, and barriers and facilitators to implementation. 
  • Innovative models of care, approaches, promising strategies, and solutions in order for clinicians and practices to routinely engage in person-centered care planning.
  • Evidence for effectiveness of strategies for implementation and delivery of person-centered care planning, their impact on improving health outcomes, as well as evidence on how to adapt, scale, and spread the intervention.

'Conservative' USPSTF Primary Prevention Statin Guidance Finalized

Questions about how to prescribe statins for primary prevention abound more than three decades after the drugs swept into clinical practice to become a first-line medical approach to cutting cardiovascular (CV) risk.

[ Read full article ]

Panelists review ADA criteria for defining ‘remission’ in type 2 diabetes

In 2021, an international expert group convened by the ADA published a consensus report on the clinical definition of “remission” in type 2 diabetes.
[ Read full article ]

Cardiovascular-related deaths in the U.S. fall, but disparities remain

Findings support personalized public health interventions to help close gaps.

[ Read full article ]

HF ‘most expensive’ comorbidity, exceeding $22 billion per year

An additional $22.3 billion is spent nationally on HF-related medical services each year, with the total annual expenditure for adults with HF approaching $180 billion, according to an analysis of Medical Expenditure Panel Survey data.

[ Read full article ]

The U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force is an independent, volunteer panel of national experts in disease prevention and evidence-based medicine. The Task Force works to improve the health of people nationwide by making evidence-based recommendations about clinical preventive services.

[ Visit U.S. Preventive Services Task Force website ]

NIH-supported study links poor sleep to increased risk of COPD flare-ups

Study is one of the largest to look at the links between sleep quality and COPD flare-ups.

[ Read full article ]

Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations

Prediabetes and type 2 diabetes have reached epidemic levels and are associated with major morbidity and mortality. The US Preventive Services Task Force (USPSTF) and the American Diabetes Association (ADA) recently recommended lowering the starting age for diabetes screening to 35 years to facilitate earlier detection and treatment.1,2 We estimated the proportion of asymptomatic US adults eligible for screening based on new vs current USPSTF and ADA screening guidelines, overall and among those with prediabetes or undiagnosed diabetes.

[ Read full article ]

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association


[ Read full article ]

Chronic Obstructive Pulmonary Disease: Screening

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

[ Read full article ]